{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T13:20:56Z","timestamp":1783776056276,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,4,13]],"date-time":"2007-04-13T00:00:00Z","timestamp":1176422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,4,13]],"date-time":"2007-04-13T00:00:00Z","timestamp":1176422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1007\/s11060-007-9373-8","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T13:33:37Z","timestamp":1176903217000},"page":"293-296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors"],"prefix":"10.1007","volume":"84","author":[{"given":"Herbert B.","family":"Newton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Goldlust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Pearl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,4,13]]},"reference":[{"key":"9373_CR1","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0889-8588(05)70269-0","volume":"15","author":"SM Arnold","year":"2001","unstructured":"Arnold SM, Patchell RA (2001) Diagnosis and management of brain metastases. Hematol Oncol Clin North Am 15:1085\u20131107","journal-title":"Hematol Oncol Clin North Am"},{"key":"9373_CR2","first-page":"579","volume":"19","author":"JB Posner","year":"1978","unstructured":"Posner JB, Chernik NL (1978) Intracranial metastases from systemic cancer. Adv Neurol 19:579\u2013592","journal-title":"Adv Neurol"},{"key":"9373_CR3","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s00415-002-0870-6","volume":"249","author":"R Soffietti","year":"2002","unstructured":"Soffietti R, Ruda R, Mutani R (2002) Management of brain metastases. J Neurol 249:1357\u20131369","journal-title":"J Neurol"},{"key":"9373_CR4","first-page":"911","volume":"114","author":"S Oberndorfer","year":"2002","unstructured":"Oberndorfer S, Schmal T, Lahrmann H et al (2002) The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna. Wien Klin Wochenschr 114:911\u2013916","journal-title":"Wien Klin Wochenschr"},{"key":"9373_CR5","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1046\/j.1528-1157.2003.05203.x","volume":"44","author":"B Schaller","year":"2003","unstructured":"Schaller B, Ruegg SJ (2003) Brain tumor and seizures: pathophysiology and its implications for treatment revisited. Epilepsia 44:1223\u20131232","journal-title":"Epilepsia"},{"key":"9373_CR6","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","volume":"54","author":"MJ Glantz","year":"2000","unstructured":"Glantz MJ, Cole BF, Forsyth PA et al (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors-report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurol 54:1886\u20131893","journal-title":"Neurol"},{"key":"9373_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1055\/s-2004-861530","volume":"24","author":"FG El Kamar","year":"2004","unstructured":"El Kamar FG, Posner JB (2004) Brain metastases. Semin Neurol 24:347\u2013362","journal-title":"Semin Neurol"},{"key":"9373_CR8","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.1997.15.9.3121","volume":"15","author":"MR Fetell","year":"1997","unstructured":"Fetell MR, Grossman SA, Fisher JD et al (1997) Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New approaches to Brain Tumor Therapy Central Nervous System Consortium. J Clin Oncol 15:3121\u20133128","journal-title":"J Clin Oncol"},{"key":"9373_CR9","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1210\/jc.83.7.2411","volume":"83","author":"C Liddle","year":"1998","unstructured":"Liddle C, Goodwin BJ, George J et al (1998) Separate and interactive regulation of cytochrome P450 3A4 by triidothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab 83:2411\u20132416","journal-title":"J Clin Endocrinol Metab"},{"key":"9373_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0163-7258(99)00052-2","volume":"85","author":"PN Patsalos","year":"2000","unstructured":"Patsalos PN (2000) Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther 85:77\u201385","journal-title":"Pharmacol Ther"},{"key":"9373_CR11","first-page":"5","volume":"4","author":"GH Stevens","year":"2005","unstructured":"Stevens GH (2005) Antiepileptic drug use in patients with brain tumors. Profiles in Seizure Manage 4:5\u20139","journal-title":"Profiles in Seizure Manage"},{"key":"9373_CR12","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.4088\/JCP.v65n0901","volume":"65","author":"SM Stahl","year":"2004","unstructured":"Stahl SM (2004) Psychopharmacology of anticonvulsants: levetiracetam as a synaptic vesicle protein modulator. J Clin Psychiatry 65:1162\u20131163","journal-title":"J Clin Psychiatry"},{"key":"9373_CR13","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K et al (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101:9861\u20139866","journal-title":"Proc Natl Acad Sci USA"},{"key":"9373_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1528-1157.2000.tb02945.x","volume":"41","author":"I Niespodziany","year":"2000","unstructured":"Niespodziany I, Klitgaard H, Margineanu DG (2000) Levetiracetam: modulation of high voltage activated C++ current in CA1 pyramidal neurons of rat hippocampal slices (abstract). Epilepsia 41:37","journal-title":"Epilepsia"},{"key":"9373_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1528-1157.2002.24501.x","volume":"43","author":"EA Lukyanetz","year":"2002","unstructured":"Lukyanetz EA, Shkryl VM, Kostyuk PG (2002) Selective blockade of n-type calcium channels by levetiracetam. Epilepsia 43:9\u201318","journal-title":"Epilepsia"},{"key":"9373_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/sj.bjp.0704766","volume":"136","author":"JM Rigo","year":"2002","unstructured":"Rigo JM, Hans G, Nguyen L et al (2002) The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br J Pharmacol 136:59\u2013672","journal-title":"Br J Pharmacol"},{"key":"9373_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0006-8993(03)02720-3","volume":"976","author":"V Cardile","year":"2003","unstructured":"Cardile V, Pavone A, Gulino R et al (2003) Expression of brain-derived neurotrophic factor (BDNF) and inducible nitric oxide synthase (iNOS) in rat astrocyte cultures treated with levetiracetam. Brain Res 976:227\u2013233","journal-title":"Brain Res"},{"key":"9373_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1053\/seiz.2000.0511","volume":"10","author":"E Hanon","year":"2001","unstructured":"Hanon E, Klitgaard H (2001) Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia. Seizure 10:287\u2013293","journal-title":"Seizure"},{"key":"9373_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S1059-1311(03)00096-7","volume":"12","author":"GL Wagner","year":"2003","unstructured":"Wagner GL, Wilms EB, Van Donselaar GA et al (2003) Levetiracetam: preliminary experience in patients with primary brain tumours. Seizure 12:585\u2013586","journal-title":"Seizure"},{"key":"9373_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11060-005-9080-2","volume":"78","author":"HB Newton","year":"2006","unstructured":"Newton HB, Goldlust SA, Pearl D (2006) Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol 78:157\u2013160","journal-title":"J Neurooncol"},{"key":"9373_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11060-006-9162-9","volume":"80","author":"M Maschio","year":"2006","unstructured":"Maschio M, Albani F, Baruzzi A et al (2006) Levetiracetam therapy in patients with brain tumour and epilepsy. J Neurooncol 80:97\u2013100","journal-title":"J Neurooncol"},{"key":"9373_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.seizure.2004.12.006","volume":"14","author":"TM Alsaadi","year":"2005","unstructured":"Alsaadi TM, Shatzel A, Marquez AV et al (2005) Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study. Seizure 14:139\u2013142","journal-title":"Seizure"},{"key":"9373_CR23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.seizure.2005.12.004","volume":"15","author":"A Labate","year":"2006","unstructured":"Labate A, Colosimo E, Gambardella A et al (2006) Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study. Seizure 15:214\u2013218","journal-title":"Seizure"},{"key":"9373_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1212\/01.wnl.0000252941.50833.4a","volume":"68","author":"MJ Brodie","year":"2007","unstructured":"Brodie MJ, Perucca E, Ryvlin P et al (2007) Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurol 68:402\u2013408","journal-title":"Neurol"},{"key":"9373_CR25","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1212\/01.WNL.0000123693.82339.FC","volume":"62","author":"JA French","year":"2004a","unstructured":"French JA, Kanner AM, Bautista J et al (2004a) Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy. Neurol 62:1252\u20131260","journal-title":"Neurol"},{"key":"9373_CR26","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/01.WNL.0000123695.22623.32","volume":"62","author":"JA French","year":"2004b","unstructured":"French JA, Kanner AM, Bautista J et al (2004b) Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy. Neurol 62:1261\u20131273","journal-title":"Neurol"},{"key":"9373_CR27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.18553\/jmcp.2006.12.1.55","volume":"12","author":"N Payakachat","year":"2006","unstructured":"Payakachat N, Summers KH, Barbuto JP (2006) A comparison of clinical practice guidelines in the initial pharmacological management of new-onset epilepsy in adults. J Manag Care Pharm 12:55\u201360","journal-title":"J Manag Care Pharm"},{"key":"9373_CR28","first-page":"9","volume-title":"Handbook of Clinical Neurology","author":"M Glantz","year":"1997","unstructured":"Glantz M, Recht LD (1997) Epilepsy in the cancer patient. In: Vecht CJ (ed) Handbook of Clinical Neurology. Elsevier Science, Amsterdam, pp 9\u201318"},{"key":"9373_CR29","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2125.1995.tb05796.x","volume":"40","author":"KT Kivisto","year":"1995","unstructured":"Kivisto KT, Kroemer HK, Eichelbaum M (1995) The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions. Br J Clin Pharmacol 40:523\u2013530","journal-title":"Br J Clin Pharmacol"},{"key":"9373_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/j.seminoncol.2003.11.030","volume":"30","author":"CJ Vecht","year":"2003a","unstructured":"Vecht CJ, Wagner GL, Wilms EB (2003a) Treating seizures in patients with brain tumors: drug interactions between antiepileptic and chemotherapeutic agents. Semin Oncol 30:49\u201352","journal-title":"Semin Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-007-9373-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-007-9373-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-007-9373-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-007-9373-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T07:44:03Z","timestamp":1652600643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-007-9373-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,13]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["9373"],"URL":"https:\/\/doi.org\/10.1007\/s11060-007-9373-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,13]]},"assertion":[{"value":"15 February 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}